Close Menu

Scripps Research Translational Institute

A molecular autopsy has aided a woman's search for why sudden cardiac death has stalked her family, the Wall Street Journal reports.

Genome sequences for 600 disease-free individuals over 80 years old suggest protective variants related to cognition may mitigate disease and boost healthspan.

The company said it has enlisted 23 academic and medical institutions to supply patient samples that will support the validation and launch of its tests.

The study will screen patients using a combination of genotyping and wireless sensors to develop a better diagnostic method. 

The price of WGS is at that "magic number" everyone has been waiting for, but is it enough to take genomics mainstream?

The goal of the Molecular Autopsy study is to identify genes that are associated with sudden death and previously unrecognized genetic mechanisms for the cases. 

Next-generation sequencing is steadily gaining acceptance in the healthcare community, but even ardent supporters of the technology cautioned at a recent conference that the approach should not be considered a silver bullet that can solve all previously intractable medical cases,

NEW YORK (GenomeWeb News) – Scripps Health today said that it has received a $3.75 million grant from the Qualcomm Foundation for digital medicine efforts, including genomic-based technologies, conducted at the Scripps Translational Science Institute.

By Monica Heger

Despite being the third best-selling drug in 2010, as many as one-third of cardiology patients do not respond to Bristol-Myers Squibb's blood-thinning drug Plavix (clopidogrel).

Pages

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.